These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 38240950)

  • 21. In-silico identification and exploration of small molecule coumarin-1,2,3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer.
    Kumar S; Ali I; Abbas F; Shafiq F; Yadav AK; Ghate MD; Kumar D
    Mol Divers; 2024 Dec; 28(6):4301-4324. PubMed ID: 38470555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in Surgical and Nonsurgical Aesthetic Procedures: A 14-Year Analysis of the International Society of Aesthetic Plastic Surgery-ISAPS.
    Triana L; Palacios Huatuco RM; Campilgio G; Liscano E
    Aesthetic Plast Surg; 2024 Oct; 48(20):4217-4227. PubMed ID: 39103642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in
    Ghosh S; Fan F; Powell R; Park YS; Stephan C; Kopetz ES; Ellis LM; Bhattacharya R
    Ther Adv Med Oncol; 2024; 16():17588359241303302. PubMed ID: 39664300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling of FAK-PROTAC candidates from GSK2256098 analogs for targeted protein degradation.
    Kumar V; Parate S; Ro HS; Jung TS; Lee KW
    Biochem Biophys Res Commun; 2024 Dec; 740():151001. PubMed ID: 39571228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review.
    O'Leary C; Ralphs R; Stevenson J; Smith A; Harrison J; Kiss Z; Armitage H
    Campbell Syst Rev; 2024 Jun; 20(2):e1396. PubMed ID: 38645303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M; Taylor K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular docking and DFT study of antiproliferative ribofuranose nucleoside derivatives targeting EGFR and VEGFR2in cancer cells.
    Bibi S; Urrehaman S; Akram M; Amin R; Majeed H; Khan SR; Younis S; Bai FQ
    Comput Biol Chem; 2024 Dec; 113():108187. PubMed ID: 39232259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7H6 is the predominant activating ligand driving natural killer cell-mediated killing in patients with liquid tumours: evidence from clinical, in silico, in vitro, and in vivo studies.
    Lee S; Chae SJ; Jang IH; Oh SC; Kim SM; Lee SY; Kim JH; Ko J; Kim HJ; Song IC; Kim JK; Kim TD
    EBioMedicine; 2024 Dec; 110():105459. PubMed ID: 39579618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender differences in the context of interventions for improving health literacy in migrants: a qualitative evidence synthesis.
    Aldin A; Baumeister PhD A; Chakraverty D; Monsef I; Noyes J; Kalbe E; Woopen C; Skoetz N
    Cochrane Database Syst Rev; 2024 Dec; 12(12):CD013302. PubMed ID: 39665382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.
    Edwards SJ; Karner C; Jhita T; Barton S; Marceniuk G; Yiu ZZN; Wittmann M
    Health Technol Assess; 2024 Jan; 28(4):1-113. PubMed ID: 38343072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular interactions of cucurbitacins A and B with anaplastic lymphoma kinase for lung cancer treatment.
    Saeed M; Alshammari N; Saeed A; Ayyed Al-Shammary A; Alabdallah NM; Ahmad I; Aqil F
    J Biomol Struct Dyn; 2024; 42(23):13165-13173. PubMed ID: 37921698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unveiling the anticancer mechanism of 1,2,3-triazole-incorporated thiazole-pyrimidine-isoxazoles: insights from docking and molecular dynamics simulations.
    Sireesha R; Pavani Y; Mallavarapu BD; Abbasi BA; Guttula PK; Subbarao M
    J Biomol Struct Dyn; 2024; 42(24):13803-13815. PubMed ID: 38038384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.
    Christophersen OA
    Microb Ecol Health Dis; 2012; 23():. PubMed ID: 23990836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SCORE2 is superior to SCORE in predicting the presence of carotid plaques and intima-media thickness in rheumatoid arthritis patients: a cross-sectional study using carotid ultrasound.
    Campos Fernández C; Fragío Gil JJ; González Mazarío R; Martínez Calabuig P; Román Ivorra JA
    Ther Adv Musculoskelet Dis; 2024; 16():1759720X241302667. PubMed ID: 39669696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repurposing FDA-approved drugs for COVID-19: targeting the main protease through multi-phase
    Metwaly AM; Elkaeed EB; Alsfouk AA; Ibrahim IM; Elkady H; Eissa IH
    Antivir Ther; 2024 Dec; 29(6):13596535241305536. PubMed ID: 39639531
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.